BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33315089)

  • 1. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway.
    Cui Y; Bai Y; Yang J; Yao Y; Zhang C; Liu C; Shi J; Li Q; Zhang J; Lu X; Zhang Y
    Carcinogenesis; 2021 Apr; 42(3):481-492. PubMed ID: 33315089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.
    Zhang X; Han J; Feng L; Zhi L; Jiang D; Yu B; Zhang Z; Gao B; Zhang C; Li M; Zhao L; Wang G
    Carcinogenesis; 2021 Feb; 42(1):105-117. PubMed ID: 32531052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
    Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
    Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4.
    Deng J; Wang H; Liang Y; Zhao L; Li Y; Yan Y; Zhao H; Zhang X; Zou F
    Cell Signal; 2023 Jan; 101():110517. PubMed ID: 36332797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-suppressive function of SIRT4 in human colorectal cancer.
    Miyo M; Yamamoto H; Konno M; Colvin H; Nishida N; Koseki J; Kawamoto K; Ogawa H; Hamabe A; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Doki Y; Mori M; Ishii H
    Br J Cancer; 2015 Jul; 113(3):492-9. PubMed ID: 26086877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
    Li X; Liang L; Huang L; Ma X; Li D; Cai S
    Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
    Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
    J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
    Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
    Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
    Huang G; Cheng J; Yu F; Liu X; Yuan C; Liu C; Chen X; Peng Z
    Oncol Rep; 2016 May; 35(5):2801-10. PubMed ID: 26986234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT4 suppresses the PI3K/Akt/NF‑κB signaling pathway and attenuates HUVEC injury induced by oxLDL.
    Tao Y; Yu S; Chao M; Wang Y; Xiong J; Lai H
    Mol Med Rep; 2019 Jun; 19(6):4973-4979. PubMed ID: 31059091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway.
    Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J
    Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian SIRT4 is a tumor suppressor of clear cell renal cell carcinoma by inhibiting cancer proliferation, migration and invasion.
    Wang C; Piao C; Liu J; Zhang Z; Zhu Y; Kong C
    Cancer Biomark; 2020; 29(4):453-462. PubMed ID: 32675395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
    Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
    Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.
    Zhou W; He MR; Jiao HL; He LQ; Deng DL; Cai JJ; Xiao ZY; Ye YP; Ding YQ; Liao WT; Liu SD
    Cancer Lett; 2015 Apr; 360(1):68-75. PubMed ID: 25667121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.